HIV / AIDS in the News

Rwanda’s HIV leadership on display at IAS 2025 - Aidsmap

 

Challenges in assessing self-reported adherence to antiretroviral therapy among individuals living with HIV/AIDS and mental disorders - BMC Research Notes

 

Senate tries to spare HIV/AIDS program from funding clawback - NJ Spotlight News

 

With HIV treatment at risk, health professionals and patients warn of potentially deadly Medicaid cuts - KHOU

 

Medicaid cuts threaten critical HIV care as advocates warn of potentially deadly consequences - KHOU

 

AI Set to Speed Up HIV Vaccine Research and Trials, Focusing on Fair Access | IAS 2025 - Managed Healthcare Executive

 

HIV cuts backfilled in SF budget - Bay Area Reporter

 

New Study Shows How Providers Can Use Apretude To Prevent And Treat HIV In Black Women - Black Enterprise

 

Judge extends temporary block, preventing Idaho from verifying immigration status for HIV program - Idaho Capital Sun

 

ViiV Healthcare Expands Licensing for Generic Cabotegravir to Boost HIV Prevention in Low-Income Countries - geneonline.com

 

ViiV expands licensing deal for its HIV drug in low-income countries - STAT

 

The HIV Prevention Pipeline | IAS 2025 - Managed Healthcare Executive

 

Lenacapavir’s Next Step: Turning Approval Into Access | IAS 2025 - Managed Healthcare Executive

 

Senate GOP agree to strip cuts to HIV, AIDS prevention program from Trump's clawback bill - Fox News

 

Tamar Braxton partners with Gilead for HIV awareness - Rolling Out

 

Pennsylvania to receive $1.28 million in settlement over Gilead’s illegal HIV drug kickback scheme - WTAJ

 

Zambia HIV Leader Calls Long-Acting PrEP a Big Step, But Warns Funding Cuts Could Slow Progress | IAS 2025 - Managed Healthcare Executive

 

National Latino Older Adults & HIV/AIDS Awareness Day 2025 - POZ - Health, Life and HIV

 

GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment - Fierce Pharma

 

HIV prevention gets an AI upgrade - Politico

 

Gilead inks $202M settlement over HIV speaker program (GILD) - Seeking Alpha

 

Tamar Braxton Partners with Gilead to Empower Black Women on HIV Prevention - ThisisRnB.com

 

Merck Starts Phase III Studies on Once-Monthly Pill for HIV Prevention - Yahoo

 

New drug in HIV protection - KXLY.com

 

Planting seeds in uncertain times: Holding the line on health equity in HIV - IDSA

 

Vertex secures Alyftrek coverage in England; Merck starts Phase 3 trials of HIV drug - BioPharma Dive

 

Random Needles Prick Partygoers—Expert: No PEP Needed - Medscape

 

Latinos Salud: Gay Men Needn’t be Young nor Hispanic to Receive HIV Services - Out South Florida

 

ViiV's HIV portfolio delivering on different fronts - The Pharma Letter

 

ViiV’s HIV shot preferred, as activists spotlight funding crisis at IAS 2025 - Yahoo